Press "Enter" to skip to content

FDA awards $50 million to Triangle universities for joint work on drug development process, regulatory oversight, public health information

FDA Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh RisksThe Research Triangle Center of Excellence in Regulatory Science and Innovation (CERSI) will serve as an accelerator to meet the FDA’s evolving need to access the most current scientific knowledge, and to also create a tight-knit community for regulators, academia, industry and other stakeholders.
Source: WRAL News

Be First to Comment

    Leave a Reply